{"schema_version":"secwatch.filing_event.v1","accession":"0000818479-22-000099","form_type":"8-K","ticker":"XRAY","cik":"0000818479","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.220043+00:00","generated_at":"2026-06-23T08:09:53.677542+00:00","sec_items":["1.01","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Dentsply Sirona appoints Glenn Coleman as new CFO, extends Q2 financials deadline to Nov 7","bullets":["Glenn Coleman appointed EVP and CFO effective Sept 26, 2022; succeeds interim CFO Barbara Bodem who remains advisor through Oct 24.","Coleman previously COO and CFO of Integra LifeSciences; base salary $625k, target bonus 80%, sign-on $300k, equity grant $3M.","Company obtained lender consent to extend delivery of unaudited Q2 financials from Sept 30 to Nov 7, 2022; failure could trigger default.","Audit committee continues investigation; company working to finalize financials as soon as practicable."],"urls":{"canonical":"https://secwatch.observer/filing/0000818479-22-000099","json":"https://secwatch.observer/filing/0000818479-22-000099.json","markdown":"https://secwatch.observer/filing/0000818479-22-000099.md","text":"https://secwatch.observer/filing/0000818479-22-000099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000099/0000818479-22-000099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000099/xray-20220920.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T08:09:53.677542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4cf4ae5990","claim":"Barbara Bodem changed role as Interim Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"Mr. Coleman will succeed Barbara Bodem who has served as Interim Chief Financial Officer since May 6, 2022; however, the Company and Ms. Bodem entered into an amendment to her employment agreement, dated as of September 22, 2022, pursuant to which Ms. Bodem will continue her employment with the Company as an advisor to Mr. Coleman until October 24, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000099/0000818479-22-000099-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"6d00bbbf54","claim":"Glenn G. Coleman was appointed as Executive Vice President and Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On September 22, 2022, the Company appointed Glenn G. Coleman as Executive Vice President and Chief Financial Officer of the Company effective as of September 26, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000099/0000818479-22-000099-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}